JP2023550191A5 - - Google Patents
Info
- Publication number
- JP2023550191A5 JP2023550191A5 JP2023531563A JP2023531563A JP2023550191A5 JP 2023550191 A5 JP2023550191 A5 JP 2023550191A5 JP 2023531563 A JP2023531563 A JP 2023531563A JP 2023531563 A JP2023531563 A JP 2023531563A JP 2023550191 A5 JP2023550191 A5 JP 2023550191A5
- Authority
- JP
- Japan
- Prior art keywords
- nanocage
- fusion protein
- monomer
- subunit
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063118306P | 2020-11-25 | 2020-11-25 | |
| US63/118,306 | 2020-11-25 | ||
| PCT/CA2021/051690 WO2022109743A1 (en) | 2020-11-25 | 2021-11-25 | Polypeptides targeting dr4 and/or dr5 and related compositions and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023550191A JP2023550191A (ja) | 2023-11-30 |
| JP2023550191A5 true JP2023550191A5 (cg-RX-API-DMAC7.html) | 2024-12-02 |
Family
ID=81753696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023531563A Pending JP2023550191A (ja) | 2020-11-25 | 2021-11-25 | Ｄｒ４および／またはｄｒ５を標的とするポリペプチドならびに関連する組成物および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240182544A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4251654A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023550191A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230116833A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116917339A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021386892A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3202378A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023006148A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022109743A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240101550A9 (ko) * | 2021-09-13 | 2025-12-10 | 더 호스피탈 포 식 칠드런 | 암 치료용 dr5-표적화 다중체 |
| KR20250135167A (ko) * | 2022-09-11 | 2025-09-12 | 래디언트 바이오테라퓨틱스 인크. | 다중체를 사용하는 화학요법-내성 종양의 치료 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109195626B (zh) * | 2015-10-30 | 2022-09-13 | 银河生物技术有限责任公司 | 结合死亡受体4和死亡受体5的抗体 |
| WO2019023811A1 (en) * | 2017-08-04 | 2019-02-07 | The Hospital For Sick Children | NANOPARTICLE PLATFORM FOR ANTIBODY AND VACCINE DELIVERY |
| JP2022529512A (ja) * | 2019-04-25 | 2022-06-22 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 抗体で修飾した自己集合するタンパク質ナノケージ（ｓａｐｎａ）及びその部分 |
-
2021
- 2021-11-25 WO PCT/CA2021/051690 patent/WO2022109743A1/en not_active Ceased
- 2021-11-25 CN CN202180087906.XA patent/CN116917339A/zh active Pending
- 2021-11-25 AU AU2021386892A patent/AU2021386892A1/en active Pending
- 2021-11-25 EP EP21896013.6A patent/EP4251654A4/en active Pending
- 2021-11-25 KR KR1020237020902A patent/KR20230116833A/ko active Pending
- 2021-11-25 JP JP2023531563A patent/JP2023550191A/ja active Pending
- 2021-11-25 CA CA3202378A patent/CA3202378A1/en active Pending
- 2021-11-25 US US18/253,483 patent/US20240182544A1/en active Pending
- 2021-11-25 MX MX2023006148A patent/MX2023006148A/es unknown